Studies have indicated that FKBP51 influences cell proliferation and responsiveness to rapamycin by modulating NF-κB phosphorylation, thereby playing a key role in regulating glioma growth and chemoresistance through the NF-κB pathway (Jiang et al., 2008). Here, FKBP4 is linked to glioma.